Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/2014
12/10/2014CN101506168B 具有快速皮肤穿透速度的带正电荷的水溶性的芳基邻氨基苯甲酸的前药 With a fast rate of penetration of the skin of positively charged water-soluble aryl anthranilic acid prodrug
12/09/2014US8907072 Nucleic acids encoding antibody 137-26 which binds C5 and C5a
12/09/2014US8906675 Adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
12/09/2014US8906409 Acoustically sensitive drug delivery particles comprising non-lamellar forming phosphatidylcholine
12/05/2014DE202014104573U1 Pharmazeutische Zusammensetzung zur Schmerzbehandlung A pharmaceutical composition for the treatment of pain
12/04/2014US20140357586 Solid Carriers for Improved Delivery of Active Ingredients in Pharmaceutical Compositions
12/02/2014US8901280 Antibody against RGD in amino acid sequence of extracellular matrix protein and production method and use of the same
12/02/2014US8901118 Compounds and methods for kinase modulation, and indications therefor
12/02/2014US8901111 Aryl-substituted heterocyclic urea modulators of fatty acid amide hydrolase
12/02/2014US8900639 Process for obtaining a rabbit skin comprising biological active substances
11/2014
11/27/2014US20140349940 Prevention and reduction of blood loss
11/27/2014US20140349391 Method of collecting placental stem cells
11/25/2014US8895733 Triazine-oxadiazoles
11/25/2014US8895625 Protective effect of thymoquinone in sepsis
11/25/2014US8895087 Composition to enhance the bioavailability of curcumin
11/20/2014US20140342930 Methods for selective targeting
11/20/2014US20140342405 Vascular endothelial growth factor 2
11/20/2014US20140342002 Particulate materials
11/18/2014US8889672 Compounds, formulations, and methods of protein kinase C inhibition
11/18/2014US8889174 Zero-order prolonged release coaxial implants
11/18/2014US8889135 Methods of administering anti-TNFα antibodies
11/13/2014US20140336158 Nk1 antagonists
11/11/2014US8883856 Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors
11/11/2014US8883849 Treatment of sleep disturbances
11/11/2014US8883777 Compositions controlling pH range of release and/or release rate
11/11/2014US8883720 Template-fixed beta-hairpin peptidomimetics with CXCR4 antagonizing activity
11/11/2014US8883715 Biocompatible polymers, process for their preparation and compositions containing them
11/11/2014US8883504 Cell differentiation suppressing agent, method of culturing cells using the same, culture solution, and cultured cell line
11/11/2014US8882075 Furnace mount
11/06/2014US20140330007 2,4-pyrimidinediamine compounds and their uses
11/06/2014US20140328878 Malleable protein matrix and uses thereof
11/04/2014US8877927 Furo[3,2-B] pyrrol -3-one derivatives and their use as cysteinyl proteinase inhibitors
11/04/2014US8877816 4-(or 5-) substituted catechol derivatives
11/04/2014US8877813 Antiinflammatory and analgesic preparation for external use
11/04/2014US8877756 Substituted pteridines
11/04/2014US8877706 Maytansinoid derivatives
11/04/2014US8877225 Controlled release copolymer formulation with improved release kinetics
11/04/2014US8877224 Compositions for preventing cardiac arrhythmia
10/2014
10/30/2014US20140325691 Regulation of endogenous gene expression in cells using zinc finger proteins
10/30/2014US20140322232 Methods of administering anti-tnfalpha antibodies
10/28/2014US8871915 Peptides targeting TNF family receptors and antagonizing TNF action, compositions, methods and uses thereof
10/28/2014US8871813 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
10/28/2014US8871791 Narcotic emulsion formulations for treatment of cancer pain
10/28/2014US8871775 Compounds
10/28/2014US8871506 Methods for treating cardio pulmonary diseases with NO group compounds
10/28/2014US8871239 Polymeric materials for medical devices
10/21/2014US8865709 Aminooxazole inhibitors of cyclin dependent kinases
10/21/2014US8865689 Methods and compositions for treating hyperuricemia and metabolic disorders associated with hyperuricemia
10/21/2014US8865643 Recombinant surfactant protein D compositions and methods of use thereof
10/21/2014US8865138 Melanin modification compositions and methods of use
10/16/2014US20140308288 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
10/14/2014US8859855 Chimeric PUFA polyketide synthase systems and uses thereof
10/14/2014US8859568 Pyrrolo[3,2-D]pyrimidin-4-one derivatives and their use in therapy
10/14/2014US8859538 Uses of substituted imidazoheterocycles
10/14/2014US8859525 Pharmaceutical compositions comprising mushroom-based polysaccharides and uses thereof
10/14/2014US8858970 High load dispersions
10/09/2014WO2014165449A1 NOVEL α4β7 PEPTIDE ANTAGONISTS
10/09/2014WO2014165057A1 Compositions and methods for treating infectious disease
10/09/2014WO2014164703A1 Delivery of card protein as therapy for occular inflammation
10/09/2014WO2014164282A1 Use of levocetirizine and montelukast in the treatment of traumatic injury
10/09/2014WO2014164281A1 Use of levocetirizine and montelukast in the treatment of anaphylaxis
10/09/2014WO2014163030A1 Preparation for treating equine inflammation
10/09/2014WO2014162313A1 Anti-inflammatory synergistic combinations comprising omega-3 fatty acid and tomato lycopene
10/09/2014WO2014162122A1 Kinase inhibitor
10/09/2014WO2014162121A1 Kinase inhibitors based upon n-alkyl pyrazoles
10/09/2014WO2014162010A1 Barettin and derivatives thereof for medical use, in particular for the treatment of diseases related to oxidative stress or inflammation, and for preserving or washing organs
10/09/2014WO2014161031A1 Nanoparticles for drug delivery comprising albumin having a polymer chain coupled thereto
10/09/2014US20140303215 Topically applicable pharmaceutical preparation
10/09/2014US20140303154 2,4-pyridinediamine compounds and their uses
10/09/2014US20140302143 Controlled Release and Taste Masking Oral Pharmaceutical Compositions
10/09/2014US20140302139 Controlled Release and Taste Masking Oral Pharmaceutical Compositions
10/08/2014EP2786996A1 Purinone derivative hydrochloride
10/08/2014EP2785843A1 Novel enhanced selectin antagonists
10/08/2014EP2785828A1 Human-derived bacteria that induce proliferation or accumulation of regulatory t cells
10/08/2014EP2785692A1 Substituted anilines as ccr(4) antagonists
10/07/2014US8853397 2,4-pyrimidinediamine compounds and their uses
10/07/2014US8853357 High purity lipopeptides
10/07/2014US8853264 Use of lignan compounds for treating or preventing inflammatory disease
10/07/2014US8853216 Hydroxylated pyrimidyl cyclopentane as AKT protein kinase inhibitor
10/07/2014US8853212 Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes
10/07/2014US8853200 Treatment of rheumatoid arthritis with 3-amino lactam compounds
10/07/2014US8853199 Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
10/07/2014US8853193 Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositions
10/07/2014US8853187 Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof
10/02/2014WO2014160579A1 Combination anti-inflammatory ophthalmic compositions
10/02/2014WO2014160508A1 Methods and compositions for treating cancer and inflammatory diseases
10/02/2014WO2014160502A1 Uridine nucleoside derivatives, compositions and methods of use
10/02/2014WO2014159725A1 Proteins specific for baff and b7rp1 and uses thereof
10/02/2014WO2014158654A1 Ship1 modulators and methods related thereto
10/02/2014WO2014157918A1 Pharmaceutical composition for inhibiting immune response through inducing differentiation into regulator t cells and promoting proliferation of regulator t cells
10/02/2014WO2014157740A1 Pyrazole derivative
10/02/2014WO2014157607A1 Method for improving optical purity of 2-hydroxycarboxylic acid or derivative thereof
10/02/2014WO2014157603A1 Pharmaceutical composition for oral administration
10/02/2014WO2014157569A1 Heterocyclic compound
10/02/2014WO2014157436A1 Pharmaceutical composition for external application
10/02/2014WO2014157382A1 Sphingosine kinase inhibitor
10/02/2014WO2014154897A1 NOVEL N-ACYL-(3-SUBSTITUTED)-(8-METHYL)-5,6-DIHYDRO-[1,2,4]TRIAZOLO[4,3-a]PYRAZINES AS SELECTIVE NK-3 RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITION, METHODS FOR USE IN NK-3 RECEPTOR-MEDIATED DISORDERS
10/02/2014WO2014154896A1 NOVEL N-ACYL-(3-SUBSTITUTED)-5,6,7,8-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-a]PYRAZINES AS SELECTIVE NK-3 RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITION, METHODS FOR USE IN NK-3 RECEPTOR-MEDIATED DISORDERS
10/02/2014WO2014154895A1 NOVEL N-ACYL-(3-SUBSTITUTED)-(8-SUBSTITUTED)-5,6-DIHYDRO- [1,2,4]TRIAZOLO[4,3-a]PYRAZINES AS SELECTIVE NK-3 RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITION, METHODS FOR USE IN NK-3 RECEPTOR-MEDIATED DISORDERS
10/02/2014WO2014154747A1 Extraction of tramadol from nauclea latifolia smith
1 ... 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 ... 1272